[Choice of radical gastrectomy type II or III (R2, R3) for gastric cancer and its 5-year survival rate].
Of 453 patients with primary gastric cancer, 364 were treated from 1979 to 1988 by radical gastrectomy type R2 or R3. The 1-year survival rate was 96.2% (329/342), 3-year survival rate 83.2% (283/286) and 5-year survival rate 58.5% (86/147). This 5-year survival rate has significantly been improved as compared with that of our previous reports in 1964 (19.6%) and 1972 (39.5%) as well as those from other institutes in China (30-40%). The improvement of treatment result is due to: 1. Adequate selection and application of radical gastrectomy, Type II or III operation and thorough resection of lymph node (N2, N3) metastasis and abdominal wall invasion, 2. Increased incidence of early lesions, and 3. better follow-up. TNM classification, histologic growth pattern, lymph node metastasis, gross type and site of primary cancer all play significant roles in prognosis.
Zhang
W F
WF
Cancer Institute, China University of Medical Sciences, Shengyang.
D005743:Gastrectomy / Q000379:methods* / Q000401:mortality; D006801:Humans; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D009361:Neoplasm Invasiveness; D013274:Stomach Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D015996:Survival Rate